FDA Approves JUVÉDERM VOLBELLA XC for Undereye Hollows
Allergan Aesthetics, an AbbVie company, announces the FDA approval of JUVÉDERM VOLBELLA XC for improvement of infraorbital hollows in adults over the age of 21.
Allergan Aesthetics, an AbbVie company, announces the FDA approval of JUVÉDERM VOLBELLA XC for improvement of infraorbital hollows in adults over the age of 21.
New research behind the Skin Quality Index highlights how inconsistent terminology may affect aesthetic consultations, treatment planning, and patient understanding.